How does the Classen Immunotherapies Inc. v. Biogen IDEC case exemplify meaningful limitations?
The Classen Immunotherapies Inc. v. Biogen IDEC case provides another important example of meaningful limitations in patent eligibility. This case involved methods related to immunization schedules and their effects on chronic immune-mediated disorders. MPEP 2106.05(e) explains: “Although the analysis step was an abstract mental process that collected and compared known information, the immunization step was…
Read More